Bronson Point Management Has Increased Its Constellium Nv (CSTM) Holding; Prothena PLC (PRTA)’s Sentiment Is 1.71

September 25, 2017 - By Stephen Andrade

Bronson Point Management Llc increased Constellium Nv (CSTM) stake by 4.53% reported in 2017Q2 SEC filing. Bronson Point Management Llc acquired 106,214 shares as Constellium Nv (CSTM)’s stock declined 23.17%. The Bronson Point Management Llc holds 2.45M shares with $16.90 million value, up from 2.34M last quarter. Constellium Nv now has $1.09B valuation. It closed at $10.3 lastly. It is down 20.46% since September 25, 2016 and is uptrending. It has outperformed by 3.76% the S&P500.

Prothena Corporation Public Limited Company is a global biotechnology company. The company has market cap of $2.46 billion. The Firm is focused on the discovery, development and commercialization of immunotherapies for the treatment of diseases that involve protein misfolding or cell adhesion. It currently has negative earnings. The Company’s clinical pipeline of antibody product candidates targets a range of indications, including Amyloid Light-chain amyloidosis (NEOD001), Parkinson’s disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).

Bronson Point Management Llc decreased Advance Auto Parts Inc (NYSE:AAP) stake by 50,000 shares to 20,000 valued at $2.33M in 2017Q2. It also reduced Hi (NYSE:HCLP) stake by 275,000 shares and now owns 525,000 shares. Colgate Palmolive Co (NYSE:CL) was reduced too.

Among 12 analysts covering Constellium NV (NYSE:CSTM), 7 have Buy rating, 0 Sell and 5 Hold. Therefore 58% are positive. Constellium NV had 17 analyst reports since August 6, 2015 according to SRatingsIntel. The firm has “Outperform” rating by Credit Suisse given on Friday, March 11. The stock of Constellium NV (NYSE:CSTM) earned “Buy” rating by Seaport Global on Wednesday, November 23. JP Morgan maintained the shares of CSTM in report on Wednesday, March 16 with “Overweight” rating. Cowen & Co initiated Constellium NV (NYSE:CSTM) on Monday, September 21 with “Market Perform” rating. Sterne Agee CRT maintained it with “Buy” rating and $12 target in Friday, October 2 report. The rating was maintained by Cowen & Co with “Hold” on Thursday, July 27. The firm has “Market Perform” rating given on Friday, July 28 by BMO Capital Markets. The firm has “Neutral” rating by Seaport Global given on Friday, September 9. Seaport Global downgraded the shares of CSTM in report on Friday, July 28 to “Hold” rating. As per Monday, October 5, the company rating was maintained by Deutsche Bank.

Since January 1, 0001, it had 0 buys, and 1 sale for $195,523 activity.

Analysts await Prothena Corporation PLC (NASDAQ:PRTA) to report earnings on November, 7. They expect $-1.38 EPS, down 9.52% or $0.12 from last year’s $-1.26 per share. After $-0.46 actual EPS reported by Prothena Corporation PLC for the previous quarter, Wall Street now forecasts 200.00% negative EPS growth.

Palo Alto Investors Llc holds 2.71% of its portfolio in Prothena Corporation PLC for 1.07 million shares. Opaleye Management Inc. owns 85,000 shares or 1.92% of their US portfolio. Moreover, Redmile Group Llc has 1.68% invested in the company for 509,698 shares. The Quebec – Canada-based Sectoral Asset Management Inc has invested 0.89% in the stock. Rock Springs Capital Management Lp, a Maryland-based fund reported 309,500 shares.

The stock decreased 0.60% or $0.39 during the last trading session, reaching $64.37. About 197,235 shares traded. Prothena Corporation PLC (PRTA) has risen 41.05% since September 25, 2016 and is uptrending. It has outperformed by 24.35% the S&P500.

Ratings analysis reveals 100% of Prothena’s analysts are positive. Out of 3 Wall Street analysts rating Prothena, 3 give it “Buy”, 0 “Sell” rating, while 0 recommend “Hold”. The lowest target is $69.0 while the high is $86.0. The stock’s average target of $76.67 is 19.11% above today’s ($64.37) share price. PRTA was included in 3 notes of analysts from December 21, 2016. On Wednesday, April 12 the stock rating was initiated by Cantor Fitzgerald with “Overweight”. The stock of Prothena Corporation PLC (NASDAQ:PRTA) earned “Overweight” rating by Piper Jaffray on Wednesday, April 12. SunTrust initiated the stock with “Buy” rating in Wednesday, December 21 report.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By : XYZScripts.com